Pharmaceutical application of rhein as S100A8 inhibitor in inflammatory diseases

A technology for S100A8 and inflammatory diseases, applied in skin diseases, cardiovascular system diseases, medical preparations containing active ingredients, etc., can solve the inability to distinguish the specific mechanism of action of S100A8 and S100A9 proteins, and the gaps in disease research and pharmacological research and development, etc. problem, achieve the effect of reducing the expression level and reducing the activation effect

Pending Publication Date: 2021-05-07
北京市中医研究所
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in this type of research, it is impossible to distinguish the specific mechanism of action of S100A8 and S100A9 proteins in the pathological link of the disease, resulting in a gap in disease research and pharmacological research and development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical application of rhein as S100A8 inhibitor in inflammatory diseases
  • Pharmaceutical application of rhein as S100A8 inhibitor in inflammatory diseases
  • Pharmaceutical application of rhein as S100A8 inhibitor in inflammatory diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only It is an embodiment of a part of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts shall fall within the protection scope of the present invention.

[0028] It should be noted that the terms "first" and "second" in the description and claims of the present invention and the above drawings are used to distinguish similar objects, but not necessarily used to describe a specific sequence or sequence. It is to be understood that the data so used are interchangeable under appropriate circ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical application of rhein as an S100A8 inhibitor in inflammatory diseases. The invention determines that rhein can be specifically combined with S100A8 protein, so that the level of inflammatory cytokines in an imiquimod-induced inflammatory skin disease model is reduced, and the inflammatory performance of skin is relieved. The invention suggests that rhein as a specific inhibitor of S100A8 has a potential therapeutic effect in S100A 8-related diseases such as inflammatory diseases.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to the pharmaceutical application of rhein as an inhibitor of S100A8 in inflammatory diseases. Background technique [0002] S100A8 is called calprotectin, and its genes are all located on human chromosome lq21. The protein consists of 93 amino acid residues, and its relative molecular mass is 10800. S100A8 and S100A9 are calcium-binding proteins of the S100 protein family, which act as calcium ion sensors and are constitutively expressed in neutrophils and monocytes. Under normal circumstances, S100A8 and S100A9 are stably combined in the form of heterodimers / tetramers in the cell, causing changes in protein conformation by combining with Ca2+, exposing the target protein binding site, and passing through toll-like receptor 4 (toll-like receptor4, TLR4) and receptor of advanced glycosylation end product (receptor of advanced glycosylation end product, RAGE) and other receptors ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/192A61P17/06A61P29/00A61P35/00A61P9/10
CPCA61K31/192A61P9/10A61P17/06A61P29/00A61P35/00
Inventor 底婷婷李萍赵京霞王燕郭肖瑶赵宁
Owner 北京市中医研究所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap